<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Bijlsma, E.K.</title>
    <link>http://repub.eur.nl/res/aut/11278/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>A G--&gt;A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2 (Article)</title>
      <link>http://repub.eur.nl/res/pub/8773/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>We describe a G--&gt;A transition within intron 5 of the NF2 gene. This
          mutation creates a consensus splice branch point sequence. To our
          knowledge this is the first report of a mutation that creates a functional
          branch point sequence in a human hereditary disorder. The new branch point
          sequence is located 18 bp upstream of a consensus splice acceptor site. A
          consensus splice donor site is found 106 bp 3' of the acceptor site. Asa
          consequence the G--&gt;A transition results in an alternatively spliced mRNA
          containing an additional exon 5a of 106 bp derived from intron sequences.
          We cloned the mutant cDNA and show that due to an in-frame stop codon the
          cDNA codes for a truncated NF2 protein. The mutation was observed in three
          affected members of an NF2 family. In a tumour of one of the family
          members both alternatively spliced and wild-type mRNA were found, although
          the wild-type allele of the gene is absent due to an interstitial deletion
          on chromosome 22. We also show that immunoprecipitations reveal the
          presence of full-length wild-type NF2 protein in the tumour lysate. These
          data support the hypothesis that some degree of normal splicing of the
          mutant precursor RNA is taking place. It is therefore likely that this
          residual activity of the mutant allele explains the relatively mild
          phenotype in the family. These data also indicate that complete
          inactivation of the gene is not required for tumour formation.</description>
    </item>
  </channel>
</rss>